3.連結財務諸表及び主な注記
(1)連結貸借対照表
| | (単位:百万円) |
| 前連結会計年度 (2025年3月31日) | 当連結会計年度 (2026年3月31日) |
資産の部 | | |
流動資産 | | |
現金及び預金 | 16,183 | 15,502 |
受取手形及び売掛金 | 22,800 | 20,904 |
電子記録債権 | 4,196 | 4,152 |
商品及び製品 | 15,379 | 15,240 |
仕掛品 | 4,860 | 3,141 |
原材料及び貯蔵品 | 6,753 | 5,498 |
その他 | 1,260 | 955 |
貸倒引当金 | △19 | △43 |
流動資産合計 | 71,416 | 65,352 |
固定資産 | | |
有形固定資産 | | |
建物及び構築物 | 47,621 | 48,583 |
減価償却累計額 | △30,544 | △31,067 |
建物及び構築物(純額) | 17,077 | 17,516 |
機械装置及び運搬具 | 75,559 | 66,142 |
減価償却累計額 | △67,927 | △57,204 |
機械装置及び運搬具(純額) | 7,632 | 8,938 |
工具、器具及び備品 | 7,698 | 7,895 |
減価償却累計額 | △6,421 | △6,605 |
工具、器具及び備品(純額) | 1,276 | 1,289 |
土地 | 13,493 | 13,259 |
建設仮勘定 | 5,040 | 2,163 |
有形固定資産合計 | 44,520 | 43,167 |
無形固定資産 | | |
のれん | 777 | 666 |
その他 | 273 | 465 |
無形固定資産合計 | 1,050 | 1,132 |
投資その他の資産 | | |
投資有価証券 | 5,120 | 6,215 |
退職給付に係る資産 | 104 | 150 |
繰延税金資産 | 648 | 715 |
その他 | 489 | 515 |
貸倒引当金 | △31 | △31 |
投資その他の資産合計 | 6,332 | 7,565 |
固定資産合計 | 51,903 | 51,864 |
資産合計 | 123,319 | 117,216 |
| | (単位:百万円) |
| 前連結会計年度 (2025年3月31日) | 当連結会計年度 (2026年3月31日) |
負債の部 | | |
流動負債 | | |
支払手形及び買掛金 | 8,561 | 8,632 |
短期借入金 | 11,512 | 8,357 |
未払法人税等 | 767 | 1,275 |
賞与引当金 | 1,341 | 1,338 |
その他の引当金 | 124 | 117 |
その他 | 5,603 | 5,551 |
流動負債合計 | 27,910 | 25,272 |
固定負債 | | |
転換社債型新株予約権付社債 | 3,000 | 3,000 |
長期借入金 | 7,406 | 4,643 |
環境対策引当金 | 145 | 166 |
退職給付に係る負債 | 4,547 | 4,117 |
繰延税金負債 | 642 | 878 |
その他 | 280 | 215 |
固定負債合計 | 16,022 | 13,021 |
負債合計 | 43,933 | 38,293 |
純資産の部 | | |
株主資本 | | |
資本金 | 21,838 | 21,838 |
資本剰余金 | 16,774 | 14,300 |
利益剰余金 | 37,767 | 38,339 |
自己株式 | △1,701 | △1,706 |
株主資本合計 | 74,679 | 72,771 |
その他の包括利益累計額 | | |
その他有価証券評価差額金 | 2,223 | 3,026 |
繰延ヘッジ損益 | △6 | △14 |
為替換算調整勘定 | 1,151 | 1,255 |
退職給付に係る調整累計額 | 207 | 633 |
その他の包括利益累計額合計 | 3,576 | 4,901 |
新株予約権 | 35 | 35 |
非支配株主持分 | 1,095 | 1,214 |
純資産合計 | 79,386 | 78,923 |
負債純資産合計 | 123,319 | 117,216 |
E0078040780堺化学工業株式会社Sakai Chemical Industry Co.,Ltd通期第1号参考様式 [日本基準](連結)Japan GAAPtrueCTECTE2025-04-012026-03-31FY2026-03-312024-04-012025-03-312025-03-311falsefalsefalse407802024-04-012025-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember407802024-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember407802024-03-31jppfs_cor:CapitalStockMember407802024-03-31jppfs_cor:CapitalSurplusMember407802024-03-31jppfs_cor:RetainedEarningsMember407802024-03-31jppfs_cor:TreasuryStockMember407802024-03-31jppfs_cor:ShareholdersEquityMember407802024-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember407802024-03-31jppfs_cor:DeferredGainsOrLossesOnHedgesMember407802024-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember407802024-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember407802024-03-31jppfs_cor:NonControllingInterestsMember407802024-04-012025-03-31jppfs_cor:RetainedEarningsMember407802024-04-012025-03-31jppfs_cor:CapitalStockMember407802024-04-012025-03-31jppfs_cor:CapitalSurplusMember407802024-04-012025-03-31jppfs_cor:TreasuryStockMember407802024-04-012025-03-31jppfs_cor:ShareholdersEquityMember407802024-04-012025-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember407802024-04-012025-03-31jppfs_cor:DeferredGainsOrLossesOnHedgesMember407802024-04-012025-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember407802024-04-012025-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember407802025-03-31jppfs_cor:CapitalStockMember407802024-04-012025-03-31jppfs_cor:NonControllingInterestsMember407802025-03-31jppfs_cor:CapitalSurplusMember407802025-03-31jppfs_cor:RetainedEarningsMember407802025-04-012026-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember407802025-03-31jppfs_cor:TreasuryStockMember407802025-04-012026-03-31jppfs_cor:ShareholdersEquityMember407802026-03-31jppfs_cor:ShareholdersEquityMember407802026-03-31jppfs_cor:CapitalStockMember407802026-03-31jppfs_cor:CapitalSurplusMember407802026-03-31jppfs_cor:RetainedEarningsMember407802026-03-31jppfs_cor:TreasuryStockMember407802026-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember407802026-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember407802026-03-31jppfs_cor:DeferredGainsOrLossesOnHedgesMember407802026-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember407802026-03-31jppfs_cor:NonControllingInterestsMember407802025-04-012026-03-31jppfs_cor:CapitalSurplusMember407802025-04-012026-03-31jppfs_cor:RetainedEarningsMember407802025-04-012026-03-31jppfs_cor:TreasuryStockMember407802025-04-012026-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember407802025-04-012026-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember407802025-04-012026-03-31jppfs_cor:DeferredGainsOrLossesOnHedgesMember407802025-04-012026-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember407802025-04-012026-03-31jppfs_cor:NonControllingInterestsMember407802025-03-31jpcrp_cor:ReportableSegmentsMember407802025-03-31jpcrp_cor:UnallocatedAmountsAndEliminationMember407802024-04-012025-03-31jpcrp_cor:ReportableSegmentsMember407802024-04-012025-03-31jpcrp_cor:UnallocatedAmountsAndEliminationMember407802026-03-31jpcrp_cor:ReconcilingItemsMember407802025-04-012026-03-31jpcrp_cor:ReconcilingItemsMember407802025-03-31jpcrp_cor:ReconcilingItemsMember407802024-04-012025-03-31jpcrp_cor:ReconcilingItemsMember407802026-03-31jpcrp_cor:OtherReportableSegmentsMember407802025-04-012026-03-31jpcrp_cor:OtherReportableSegmentsMember407802025-03-31jpcrp_cor:OtherReportableSegmentsMember407802024-04-012025-03-31jpcrp_cor:OtherReportableSegmentsMember407802026-03-31tse-acedjpfr-40780:ElectronicMaterialsReportableSegmentMember407802026-03-31tse-acedjpfr-40780:CosmeticsMaterialsReportableSegmentMember407802026-03-31tse-acedjpfr-40780:OrganicChemicalsReportableSegmentMember407802026-03-31tse-acedjpfr-40780:HygienicProductsReportableSegmentMember407802026-03-31tse-acedjpfr-40780:ContractProcessingReportableSegmentMember407802026-03-31tse-acedjpfr-40780:TitaniumDioxideAndZincProductsWithoutCosmeticsMaterialsReportableSegmentMember407802026-03-31tse-acedjpfr-40780:PlasticAdditivesReportableSegmentMember407802026-03-31tse-acedjpfr-40780:CatalystsReportableSegmentMember407802026-03-31tse-acedjpfr-40780:MedicalBusinessReportableSegmentMember407802025-04-012026-03-31tse-acedjpfr-40780:ElectronicMaterialsReportableSegmentMember407802025-04-012026-03-31tse-acedjpfr-40780:CosmeticsMaterialsReportableSegmentMember407802025-04-012026-03-31tse-acedjpfr-40780:OrganicChemicalsReportableSegmentMember407802025-04-012026-03-31tse-acedjpfr-40780:HygienicProductsReportableSegmentMember407802025-04-012026-03-31tse-acedjpfr-40780:ContractProcessingReportableSegmentMember407802025-04-012026-03-31tse-acedjpfr-40780:TitaniumDioxideAndZincProductsWithoutCosmeticsMaterialsReportableSegmentMember407802025-04-012026-03-31tse-acedjpfr-40780:PlasticAdditivesReportableSegmentMember407802025-04-012026-03-31tse-acedjpfr-40780:CatalystsReportableSegmentMember407802025-04-012026-03-31tse-acedjpfr-40780:MedicalBusinessReportableSegmentMember407802025-03-31tse-acedjpfr-40780:ElectronicMaterialsReportableSegmentMember407802025-03-31tse-acedjpfr-40780:CosmeticsMaterialsReportableSegmentMember407802025-03-31tse-acedjpfr-40780:OrganicChemicalsReportableSegmentMember407802025-03-31tse-acedjpfr-40780:HygienicProductsReportableSegmentMember407802025-03-31tse-acedjpfr-40780:ContractProcessingReportableSegmentMember407802025-03-31tse-acedjpfr-40780:TitaniumDioxideAndZincProductsWithoutCosmeticsMaterialsReportableSegmentMember407802025-03-31tse-acedjpfr-40780:PlasticAdditivesReportableSegmentMember407802025-03-31tse-acedjpfr-40780:CatalystsReportableSegmentMember407802025-03-31tse-acedjpfr-40780:MedicalBusinessReportableSegmentMember407802024-04-012025-03-31tse-acedjpfr-40780:ElectronicMaterialsReportableSegmentMember407802024-04-012025-03-31tse-acedjpfr-40780:CosmeticsMaterialsReportableSegmentMember407802024-04-012025-03-31tse-acedjpfr-40780:OrganicChemicalsReportableSegmentMember407802024-04-012025-03-31tse-acedjpfr-40780:HygienicProductsReportableSegmentMember407802024-04-012025-03-31tse-acedjpfr-40780:ContractProcessingReportableSegmentMember407802024-04-012025-03-31tse-acedjpfr-40780:TitaniumDioxideAndZincProductsWithoutCosmeticsMaterialsReportableSegmentMember407802024-04-012025-03-31tse-acedjpfr-40780:PlasticAdditivesReportableSegmentMember407802024-04-012025-03-31tse-acedjpfr-40780:CatalystsReportableSegmentMember407802024-04-012025-03-31tse-acedjpfr-40780:MedicalBusinessReportableSegmentMember407802026-03-31tse-acedjpfr-40780:InorganicMaterialsReportableSegmentMember407802025-04-012026-03-31tse-acedjpfr-40780:InorganicMaterialsReportableSegmentMember407802025-03-31tse-acedjpfr-40780:InorganicMaterialsReportableSegmentMember407802024-04-012025-03-31tse-acedjpfr-40780:InorganicMaterialsReportableSegmentMember407802026-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember407802025-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember407802025-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember407802025-03-31jppfs_cor:DeferredGainsOrLossesOnHedgesMember407802025-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember407802025-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember407802025-03-31jppfs_cor:NonControllingInterestsMember407802025-04-012026-03-31jppfs_cor:CapitalStockMember407802025-03-31jppfs_cor:ShareholdersEquityMember407802026-05-13407802026-03-31407802025-04-012026-03-31407802025-03-31407802024-04-012025-03-31407802024-03-31407802026-03-31jppfs_cor:SubscriptionRightsToSharesMember407802025-04-012026-03-31jppfs_cor:SubscriptionRightsToSharesMember407802025-03-31jppfs_cor:SubscriptionRightsToSharesMember407802024-04-012025-03-31jppfs_cor:SubscriptionRightsToSharesMember407802024-03-31jppfs_cor:SubscriptionRightsToSharesMember407802026-03-31jpcrp_cor:ReportableSegmentsMember407802026-03-31jpcrp_cor:UnallocatedAmountsAndEliminationMember407802025-04-012026-03-31jpcrp_cor:ReportableSegmentsMember407802025-04-012026-03-31jpcrp_cor:UnallocatedAmountsAndEliminationMemberxbrli:pureiso4217:JPY